Charles N. Serhan Explained

Charles Nicholas Serhan is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School and a professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine.[1] Serhan is the Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women's Hospital.

Education

Serhan completed his Bachelor of Science in biochemistry at State University of New York at Stony Brook in 1978.[2] In 1982, Serhan earned a doctorate in Experimental Pathology and Medical Sciences from New York University School of Medicine. Following his graduation, Serhan began a postdoctoral fellowship at the Karolinska Institute in Stockholm, Sweden under the mentorship of Bengt Samuelsson.[3] Serhan has also received honorary degrees from Harvard University, University College Dublin,[4] and Queen Mary College, University of London.[5]

Career

The focus of Serhan's research are Specialized Pro-Resolving Mediators (SPMs), which are "inflammation-fighting molecules in the body derived from essential fatty acids".[6] While working with Mats Hamberg and Bengt Samuelsson at the Karolinska Institute, Serhan helped discover lipoxin[7] the first of the SPMs to be elucidated.[8] Since this initial discovery, Serhan has identified additional mediators including Resolvins, Maresins, and Protectins.[9]

Serhan became a faculty member at Harvard Medical School in 1987 and the Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women's Hospital (CET&RI). The CET&RI's mission is: "To identify novel mediators, pathways, and their cellular receptors and targets critical in promoting resolution of inflammation and reperfusion tissue injury and establish their relation to human disease".[10]

Awards and honors

Serhan was awarded the John Vane Medal from The William Harvey Research Institute in 2008.[11] In 2016, he received the Ross Prize in Molecular Medicine.[12] He was awarded the International Eicosanoid Research Foundation's 2017 Lifetime Achievement Award.[13] Serhan was the American Society for Investigative Pathology (ASIP) Rous-Whipple Award recipient in 2018[14] and became an Honorary Life Member of the Society for Leukocyte Biology in 2019.[15] In 2022, Serhan delivered the Hans L. Falk Memorial Lecture at the National Institute of Environmental Health Sciences.[16]

External links

Notes and References

  1. Web site: Prof. Charles Serhan, PhD, Research - Brigham and Women's Hospital . 2022-12-27 . www.brighamandwomens.org . en.
  2. Web site: Charles Serhan Harvard Medical School - Academia.edu . 2022-12-27 . hms-harvard.academia.edu.
  3. Web site: Charles N. Serhan, Ph.D. . 2022-12-27 . www.science.org . en.
  4. Web site: Charles Serhan - UCD President's Office . 2022-12-27 . www.ucd.ie.
  5. Web site: Fellows - Queen Mary University of London . 2022-12-27 . www.qmul.ac.uk.
  6. Web site: Communication . Brigham Office of Strategic . 2021-03-11 . Your Food, Your Genes, and COVID-19: Q&A with Charles N. Serhan . 2022-12-27 . Brigham Clinical & Research News . en-US.
  7. Serhan . C N . Hamberg . M . Samuelsson . B . 1984 . Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes . Proc Natl Acad Sci USA . 81 . 17 . 5335–5339 . 10.1073/pnas.81.17.5335 . 6089195 . 391698 . 1984PNAS...81.5335S . free .
  8. Web site: 2022-03-04 . The end of inflammation? New approach could treat dozens of diseases. . https://web.archive.org/web/20220304132043/https://www.nationalgeographic.com/science/article/the-end-of-inflammation-new-approach-could-treat-dozens-of-diseases . dead . March 4, 2022 . 2022-12-27 . National Geographic . en.
  9. Web site: Research Features . 2017-06-19 . Lipid mediators put an end to inflammation . 2022-12-27 . Research Features . en-GB.
  10. Web site: Serhan Lab – Brigham and Women's Hospital . 2022-12-27 . en-US.
  11. Web site: Award Winners - The William Harvey Research Institute - Faculty of Medicine and Dentistry . 2022-12-27 . www.qmul.ac.uk.
  12. Web site: Gentile . Marie . 2016-06-02 . Inflammation Researcher to Receive 2016 Ross Prize . 2022-12-27 . The New York Academy of Sciences.
  13. Web site: ACHIEVEMENT AWARD – Bioactive Lipids in Cancer, Inflammation and Related Diseases . 2022-12-27 . en-US.
  14. Web site: Dr. Charles N. Serhan Receives the ASIP 2018 Rous-Whipple Award . 2022-12-27 . www.newswise.com . en.
  15. Web site: Honorary Life Members . 2022-12-27 . www.leukocytebiology.org.
  16. Web site: Falk Memorial Lecture focuses on how inflammation ends (Environmental Factor, April 2022) . 2022-12-27 . National Institute of Environmental Health Sciences . en.